News Details
19/09/2025 10:19
Aurobindo Pharma - Curateq Biologics Announces Successful Completion Of Phase 3 Clinical Study For Denosumab Biosimilar.
Submission of disclosure of successful of phase 3 clinical study for Denosumab Biosimilar by CuraTeQ Biologics Private Limited, a wholly owned subsidiary of the Company.